The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy
- PMID: 51048
- DOI: 10.1007/BF00314604
The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy
Abstract
Little is known about the influence of phenytoin and ethosuximide on primidone. Therefore we studied three groups of patients: 28 receiving primidone alone, 16 on comedication of primidone with phenytoin and 9 on primidone plus ethosuximide. Antiepileptic drug determinations were done with Kupferberg's gas chromatographic method. The results show that the addition of phenytoin--but not ethosuximide--does increase the plasma concentration of phenobarbital derived from primidone but not of primidone itself. The phenobarbital/primidone plasma concentration ratio is with 4.2 +/- 0.7 (+/- S.E.) significantly (P less than 0.001) higher in patients receiving primidone and phenytoin as compared to those on primidone alone (1.6 +/- 0.2) or together with ethosuximide (1.4 +/- 0.7). The effect of phenytoin occurs and persists for several days after the steady state plasma concentration of phenytoin has been reached. This effect is probably not due to induction of enzymes hydroxylating primidone but rather to inhibition of the metabolism and/or excretion of phenobarbital. A case of phenobarbital intoxication due to addition of phenytoin to primidone medication is described in detail.
Similar articles
-
Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient.Br J Clin Pharmacol. 1982 Aug;14(2):294-7. doi: 10.1111/j.1365-2125.1982.tb01980.x. Br J Clin Pharmacol. 1982. PMID: 7104185 Free PMC article.
-
Use of saliva in therapeutic drug monitoring.Clin Chem. 1977 Feb;23(2 PT. 1):157-64. Clin Chem. 1977. PMID: 318941
-
Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid.Epilepsia. 1975 Dec;16(5):735-41. doi: 10.1111/j.1528-1157.1975.tb04758.x. Epilepsia. 1975. PMID: 1222748
-
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.Clin Pharmacokinet. 1995 Oct;29(4):257-86. doi: 10.2165/00003088-199529040-00005. Clin Pharmacokinet. 1995. PMID: 8549027 Review.
-
Antiepileptic drugs in adolescents.J Adolesc Health Care. 1987 Jan;8(1):105-12. doi: 10.1016/0197-0070(87)90251-8. J Adolesc Health Care. 1987. PMID: 3102417 Review.
Cited by
-
Pharmacokinetic interactions with antiepileptic drugs.Clin Pharmacokinet. 1982 Jan-Feb;7(1):57-84. doi: 10.2165/00003088-198207010-00004. Clin Pharmacokinet. 1982. PMID: 7042173 Review.
-
Pharmacokinetic drug interactions with phenytoin (Part II).Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004. Clin Pharmacokinet. 1990. PMID: 2180613 Review. No abstract available.
-
Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient.Br J Clin Pharmacol. 1982 Aug;14(2):294-7. doi: 10.1111/j.1365-2125.1982.tb01980.x. Br J Clin Pharmacol. 1982. PMID: 7104185 Free PMC article.
-
Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.Clin Pharmacokinet. 1996 Dec;31(6):470-93. doi: 10.2165/00003088-199631060-00005. Clin Pharmacokinet. 1996. PMID: 8968658 Review.
-
Effect of ethanol intake on phenytoin metabolism in volunteers.Experientia. 1975 Nov 15;31(11):1313-4. doi: 10.1007/BF01945799. Experientia. 1975. PMID: 1204786